EPISODE · Aug 11, 2019 · 8 MIN
OCPs/HRT in BRCA Carriers: What’s the Evidence?
from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls
Because of the increased risk for breast cancer, BRCA mutation carriers may have concerns about taking oral contraceptives or using hormone replacement therapy after a premenopausal prophylactic bilateral salpingo-oophorectomy (removal of the ovaries and fallopian tubes). Here, we review the current literature about hormone use by BRCA mutation carriers.
Embed this episode
NOW PLAYING
OCPs/HRT in BRCA Carriers: What’s the Evidence?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.